Clinical Genetic Test
offered by
GTR Test Accession:
Help
GTR000569741.4
Last updated in GTR:
2024-01-10
View version history
GTR000569741.4,
last updated:
2024-01-10
GTR000569741.3,
last updated:
2023-01-13
GTR000569741.2,
last updated:
2020-10-20
GTR000569741.1,
registered in GTR:
2019-12-20
Last annual review date for the lab: 2024-01-11
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Prognostic
Conditions (16):
Help
Usher syndrome;
Hereditary hearing loss and deafness;
Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive
more...
Genes (9):
Help
Methods (2):
Help
Molecular Genetics - Deletion/duplication analysis: Next-Generation (NGS)/Massively parallel sequencing (MPS); ...
Target population: Help
The Usher Panel simultaneously screens 9 genes known to cause …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Buccal swab
- Isolated DNA
- Peripheral (whole) blood
- Saliva
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
- Nurse Practitioner
- Physician Assistant
Test Order Code:
Help
USH01
View other test codes
View other test codes
CPT codes:
Help
Lab contact:
Help
Amy Weaver, Administrator
[email protected]
319-335-6623
Jori Hendon, BA, Administrator
[email protected]
319-335-6653
[email protected]
319-335-6623
Jori Hendon, BA, Administrator
[email protected]
319-335-6653
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Sample types accepted include: 3-5 cc EDTA whole blood; 5 μg DNA, resuspended in at least 50 ul of DNA Elution Buffer; Saliva (DNA Genotek, ORAGene Discover, OGR-500); or Buccal Swabs, at least 4 (DNA Genotek, OraCollect, OCD-100). Samples can be received Monday - Friday (no weekend or holiday deliveries), …
Order URL
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Comment: Includes next-generation sequencing and copy number variation studies (deletion/duplication studies).
Comment: Includes next-generation sequencing and copy number variation studies (deletion/duplication studies).
Test additional service:
Help
Custom mutation-specific/Carrier testing
Test development:
Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required:
Help
Based on applicable state law
Test strategy:
Help
The Usher Panel uses custom-targeted sequence capture for DNA enrichment followed by massively parallel DNA sequencing. Data analysis is performed and results are discussed at a multidisciplinary meeting where each patient's variants are discussed individually and in the context of their unique clinical information to provide the most comprehensive diagnosis …
View more
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Conditions
Help
Total conditions: 16
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 9
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 2
Method Category
Help
Test method
Help
Instrument
Deletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Agilent SureSelect
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Agilent SureSelect
Clinical Information
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Prognostic
Target population:
Help
The Usher Panel simultaneously screens 9 genes known to cause Usher syndrome by using custom-targeted sequence capture for DNA enrichment followed by massively parallel DNA sequencing. Data analysis is performed and results are discussed at a multidisciplinary meeting. Each patient's variants are discussed individually and in the context of their …
View more
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
No.
No.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Not provided.
Not provided.
Recommended fields not provided:
Clinical validity,
Clinical utility,
What is the protocol for interpreting a variation as a VUS?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
targeted genomic enrichment and massively parallel sequencing
Test Platform:
None/not applicable
Test Confirmation:
Help
We have shown experimentally variants with QD >10 do not require Sanger sequencing validation (PMID: 21078986). In cases where the QD is between 5 and 10 and/or the zygosity status is indeterminate, Sanger confirmation is performed. Quality control testing to detect specimen mislabeling or sample contamination (sample integrity check) is …
View more
Availability:
Help
Tests performed
Interpretation performed in-house
Report generated in-house
Specimen preparation performed both in-house and at an outside lab
Wet lab work performed in-house
Test performance comments
DNA isolation from whole blood can be performed by the ordering healthcare provider's institution and/or send-out laboratory and DNA sent to MORL for testing.
Interpretation performed in-house
Report generated in-house
Specimen preparation performed both in-house and at an outside lab
Wet lab work performed in-house
Test performance comments
DNA isolation from whole blood can be performed by the ordering healthcare provider's institution and/or send-out laboratory and DNA sent to MORL for testing.
Analytical Validity:
Help
greater than 99%
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Alternative Assessment
PT Provider: Help
European Molecular Genetics Quality Network, EMQN
Description of PT method: Help
In addition to formal proficiency testing with EMQN, MORL performs in-house proficiency testing.
Yes
Method used for proficiency testing: Help
Alternative Assessment
PT Provider: Help
European Molecular Genetics Quality Network, EMQN
Description of PT method: Help
In addition to formal proficiency testing with EMQN, MORL performs in-house proficiency testing.
Recommended fields not provided:
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Reviews:
Clinical resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.